Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-08-030745
Filing Date
2008-05-19
Accepted
2008-05-19 17:26:50
Documents
2
Period of Report
2008-05-15

Document Format Files

Seq Description Document Type Size
1 v115065_ex.html 4  
1 v115065_ex.xml 4 30831
2 v115065_ex99-1.htm EX-99.1 76355
  Complete submission text file 0001144204-08-030745.txt   109290
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
SEATTLE GENETICS INC /WA (Issuer) CIK: 0001060736 (see all company filings)

EIN.: 911874389 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address J.P. MORGAN PARTNERS 270 PARK AVENUE NEW YORK NY 10017
Business Address J.P. MORGAN PARTNERS 270 PARK AVENUE NEW YORK NY 10017 212-270-2503
JP MORGAN PARTNERS BHCA LP (Reporting) CIK: 0001106607 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-32405 | Film No.: 08846174